Sociedad Americana de Hirudoterapia

Food and Drugs Department — Ministry of Health, Co-operative Republic of Guyana

Guyana FDD · Guyana · latin america

Regulatory jurisdiction profileJurisdictional reference
Unregulatednational regulator

Guyana's national food / drugs department — leech-specific authorisation pathway not independently verified by ASH.

Regulatory Profile

Agency type
national regulator
Region
latin america
Country
Guyana
Leech status
unregulated
Last ASH review
2026-05-28

Relevant Regulation Codes

  • Guyana Food and Drugs Act Cap. 34:03 and amendments
  • Caribbean Regulatory System (CRS) of CARPHA arrangements where applicable

Prescriber Requirements

  • Guyana Medical Council–registered physician — order required for any biomedical device application
  • Allied health professional application under physician supervision per institutional protocol

Supply Chain & GMP

Guyana FDD registration as applicable; English-language labelling. Standard cold-chain conditions, with logistical constraints typical of Amazonian / Caribbean distribution.

Import/Export Rules

Guyana FDD and Guyana Livestock Development Authority clearance for live invertebrates; CITES Appendix II paperwork for Hirudo medicinalis / verbana.

Reimbursement Context

Guyana's public health system coverage depends on inpatient bundling; outpatient hirudotherapy is generally not separately reimbursed.

ASH Editorial Notes

Leech-specific authorisation pathway not independently verified by ASH; falls under general medical-device / traditional-medicine framework as appropriate. CARPHA Caribbean Regulatory System reliance arrangements have not been independently mapped by ASH for live-organism medical devices.

Related Jurisdictions

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.